Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ec38905d57b9fda6d35ea26e720f958 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b5f41889212134f724ee94357d02f4b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6937 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5153 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 |
filingDate |
2016-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0e3051e6b8673c8825183445abd63e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77171c758c4d93b446d489ab9b09c443 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12464d7192588a9fc0854be95badc564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e2e3a8f023a6a5b7cf3394cb89dd79d |
publicationDate |
2018-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20180072326-A |
titleOfInvention |
Anti-cancer drug Effective for Multidrug resistant cancer cells |
abstract |
The present invention relates to a PLGA nanoparticle loaded with dobutamine and a composition for preventing or treating cancer comprising the same. The PLGA nanoparticles loaded with dobutamine according to the present invention are in the form of a nano emulsion, which remarkably improves solubility and dispersibility in an aqueous solvent, and is excellent in the selective delivery efficiency to cancer cells. In addition, it can be used as a new therapeutic agent for cancer-resistant intractable cancer which has no distinct treatment method, while expanding the application of dobutamine as a cardiovascular treatment agent. |
priorityDate |
2016-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |